Study of CXCR5 Modified EGFE Chimeric Antigen Receptor Autologous T Cells in EGFR- Positive Patients With Advanced Non-small Cell Lung Cancer

NCT04153799 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

BIOLOGICAL: CXCR5 modified EGFR Chimeric Antigen Receptor Autologous T cells

Sponsor

Sun Yat-sen University

Collaborators

[object Object]